用户名： 密码： 验证码：
Adherence to Sublingual Immunotherapy
详细信息    查看全文
Cutler DM, Everett W. Thinking outside the pillbox—medication adherence as a priority for health care reform. N Engl J Med. 2010;362(17):1553–5. The article revealing that less than 50% of patients adhere to medical treatments. CrossRef PubMed
3.••
Bousquet J, Lockey R, Malling HJ (eds) Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol. 1998;102(4):558–62. The international guidelines on allergen immunotherapy endorsed by WHO.
4.Incorvaia C, Frati F. One century of allergen-specific immunotherapy for respiratory allergy. Immunotherapy. 2011;3(5):629–35.CrossRef PubMed
5.•
Incorvaia C, Mauro M, Ridolo E, et al. Patient’s compliance with allergen immunotherapy. Patient Prefer Adherence. 2008;2:247–51. The state of the art on compliance to allergen immunotherapy in the 2000s. PubMedCentral CrossRef PubMed
6.•
Senna G, Lombardi C, Canonica GW, et al. How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers’ viewpoint. J Allergy Clin Immunol. 2010;126(3):668–9. The disclosure, based on data from manufacturers, that less of 15% of patients initiating sublingual immunotherapy reach the third year of treatment. CrossRef PubMed
7.Cavkaytar O, Akdis CA, Akdis M. Modulation of immune responses by immunotherapy in allergic diseases. Curr Opin Pharmacol. 2014;17:30–7.CrossRef PubMed
8.Senna G, Crivellaro MA, Bonadonna P, et al. Optimal dosing of allergen immunotherapy: efficacy, safety, long-lasting effect. Eur Ann Allergy Clin Immunol. 2003;35(10):386–92.PubMed
9.Makatsori M, Scadding GW, Lombardo C, Bisolfi G, Ridolo E, Durham SR, et al. Dropouts in sublingual allergen immunotherapy trials—a systematic review. Allergy. 2014;69(5):571–80.CrossRef PubMed
10.Pajno G, Vita D, Caminiti L, et al. Children’s compliance with allergen immunotherapy according to administration routes. J Allergy Clin Immunol. 2005;116(6):1380–1.CrossRef PubMed
11.•Kiel MA, Roder E, van Gerth WR, et al. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. J Allergy Clin Immunol. 2013;132(2):353–60. A recent study confirming the low compliance in real life of patients with both subcutaneous and sublingual immunotherapy. CrossRef PubMed
12.Egert-Schmidt AM, Kolbe JM, Mussler S, et al. Patient’s compliance with different administration routes for allergen immunotherapy in Germany. Patient Prefer Adherence. 2014;8:147581.
13.Pajno G, Caminiti L, Crisafulli G, et al. Adherence to sublingual immunotherapy in preschool children. Pediatr Allergy Immunol. 2012;23:688–9.CrossRef PubMed
14.Passalacqua G, Baiardini I, Senna G, et al. Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis. Clin Exp Allergy. 2013;43(1):22.8.CrossRef PubMed
15.•Bender BG. Motivating patient adherence to allergic rhinitis treatments. Curr Allergy Asthma Rep. 2015;15(3):10. An updated comprehensive review on how to improve the patient’s adherence to therapies for allergic rhinitis. CrossRef PubMed
16.Koberlein J, Kothe AC, Schaffert C. Determinants of patient compliance in allergic rhinoconjunctivitis. Curr Opin Allergy Clin Immunol. 2011;11(3):192–9.CrossRef PubMed
17.Silva D, Pereira A, Santos N, et al. Costs of treatment affect compliance to specific subcutaneous immunotherapy. Eur Ann Allergy Clin Immunol. 2014;46(2):87–94.PubMed
18.Scurati S, Frati F, Passalacqua G, et al. Adherence issues related to sublingual immunotherapy as perceived by allergists. Patient Prefer Adherence. 2010;4:141–5.PubMedCentral PubMed
19.•Incorvaia C, Rapetti A, Scurati S, et al. Importance of patient’s education in favouring compliance with sublingual immunotherapy. Allergy. 2010;65(10):1341–2. A study demonstrating the importance of patient’s education in improving compliance with sublingual immunotherapy. CrossRef PubMed
20.Savi E, Peveri S, Senna G, et al. Causes of SLIT discontinuation and strategies to improve the adherence: a pragmatic approach. Allergy. 2013;68(9):1193–5.PubMed
21.•Vita D, Caminiti L, Ruggeri P, et al. Sublingual immunotherapy: adherence based on timing and monitoring control visits. Allergy. 2010;65(5):668–9. A study showing the ability of regular patients monitoring in improving the adherence to sublingual immunotherapy. CrossRef PubMed
22.Tripodi S, Comberiati P, Di Rienzo Businco A. A web-based tool for improving adherence to sublingual immunotherapy. Pediatr Allergy Immunol. 2014;25(6):611–2.PubMed
23.Joshi S, Dimov V. Use of new technology to improve utilization and adherence to immunotherapy. World Allergy Organ J. 2014;7(1):29.PubMedCentral CrossRef PubMed
24.Sánchez J. Adherence to allergen immunotherapy improves when patients choose the route of administration: subcutaneous or sublingual. Allergol Immunopathol (Madr). 2015;43(5):436–41.CrossRef
25.Antico A. Long-term adherence to sublingual therapy: literature review and suggestions for management strategies based on patients’ needs and preferences. Clin Exp Allergy. 2014;44(11):1314–26.CrossRef PubMed
26.••Brozek JL, Akl EA, Compalati E, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy. 2011;66(5):588–95. The important approach of involving patient’s perception and opinion in prescribing medical treatments. CrossRef PubMed
27.Bender BG, Oppenheimer J. The special challenge of nonadherence with sublingual immunotherapy. J Allergy Clin Immunol Pract. 2014;2(2):152–5.CrossRef PubMed
28.Berto P, Frati F, Incorvaia C. Economic studies of immunotherapy: a review. Curr Opin Allergy Clin Immunol. 2008;8(6):585–9.CrossRef PubMed
29.Makatsori M, Senna G, Pitsios C, et al. Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol. Clin Transl Allergy. 2015;5:17.PubMedCentral CrossRef PubMed
  • 作者单位：Cristoforo Incorvaia (1)
    Marina Mauro (2)
    Gualtiero Leo (1) (3)
    Erminia Ridolo (4)

    1. Allergy/Pulmonary Rehabilitation, Istituti Clinici di Perfezionamento, via Bignami 1, 20100, Milan, Italy
    2. Allergy Unit, Sant’Anna Hospital, Como, Italy
    3. Pediatric Allergy and Respiratory Pathophysiology Unit, Vittore Buzzi Children’s Hospital, Istituti Clinici di Perfezionamento, Milan, Italy
    4. Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy
  • 刊物主题：Allergology;
  • 出版者：Springer US
  • ISSN：1534-6315
    • 文摘
    Adherence is a major issue in any medical treatment. Allergen immunotherapy (AIT) is particularly affected by a poor adherence because a flawed application prevents the immunological effects that underlie the clinical outcome of the treatment. Sublingual immunotherapy (SLIT) was introduced in the 1990s, and the early studies suggested that adherence and compliance to such a route of administration was better than the traditional subcutaneous route. However, the recent data from manufacturers revealed that only 13 % of patients treated with SLIT reach the recommended 3-year duration. Therefore, improved adherence to SLIT is an unmet need that may be achieved by various approaches. The utility of patient education and accurate monitoring during the treatment was demonstrated by specific studies, while the success of technology-based tools, including online platforms, social media, e-mail, and a short message service by phone, is currently considered to improve the adherence. This goal is of pivotal importance to fulfill the object of SLIT that is to modify the natural history of allergy, ensuring a long-lasting clinical benefit, and a consequent pharmaco-economic advantage, when patients complete at least a 3-year course of treatment.

    © 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

    地址：北京市海淀区学院路29号 邮编：100083

    电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700